Kandari Sudipta, Gupta Surbhi, Pal Simanti, Yadav Manisha, Kumar Anil, Murugavel Sevi
Department of Physics and Astrophysics, University of Delhi, Delhi 110007, India.
Dr. B. R. Ambedkar Center for Biomedical Research, University of Delhi, New Delhi 110007, India.
ACS Omega. 2025 May 6;10(19):19922-19938. doi: 10.1021/acsomega.5c01571. eCollection 2025 May 20.
Mesoporous bioactive glasses (MBGs) have emerged as promising candidates for bone defect treatment due to their ability to promote superior dissolution followed by the biomineralization process. MBGs with controllable amounts of therapeutic ions, aimed at imparting antibacterial activity as well as stimulating osteogenesis and angiogenesis, represent the newest approach to developing biomaterials. In this study, we demonstrate the nanosized MBGs with multiple biological functions, the framework of mesoporous ternary SiO-CaO-PO bioactive glass modified with a minor amount of copper ions (2% mol). The MBG obtained via the modified sol-gel method involves a combined evaporation-induced self-assembly process followed by acid extraction and ethanol treatment. The Cu-containing MBGs (Cu-MBGs) were found to possess high surface area, uniform pore size, excellent bioactivity, and sustained release of copper ions. MBGs obtained after acid and ethanol extraction processes possess a surface area greater than 500 m g with a high density of Si-OH groups. The hemolysis percentage of less than 3% suggested an excellent candidate for strong hemocompatibility. Cu-MBG nanoparticles and their ionic dissolution exhibit antimicrobial effects against Escherichia coli and Staphylococcus aureus bacteria and pronounced anticancer properties against cancer cell lines. Furthermore, the acid-extracted Cu-MBG sample demonstrated remarkable biocompatibility with human osteosarcoma cells, maintaining compatibility even at concentrations of up to 200 μg mL. These findings suggest that Cu-MBG, integrating multiple functions, holds promise for bioactivity, degradability, blood and bone cell compatibility, cancer treatment, and antibacterial efficacy, offering potential for treating infectious diseases and bone-related defects.
介孔生物活性玻璃(MBGs)因其能够促进优异的溶解并随后进行生物矿化过程,已成为骨缺损治疗的有前景的候选材料。具有可控治疗离子量的MBGs旨在赋予抗菌活性以及刺激骨生成和血管生成,代表了开发生物材料的最新方法。在本研究中,我们展示了具有多种生物学功能的纳米级MBGs,即含有少量铜离子(2%摩尔)的介孔三元SiO-CaO-PO生物活性玻璃的骨架。通过改进的溶胶-凝胶法获得的MBG涉及蒸发诱导自组装过程,随后进行酸提取和乙醇处理。发现含铜MBGs(Cu-MBGs)具有高比表面积、均匀的孔径、优异的生物活性和铜离子的持续释放。经过酸和乙醇提取过程后获得的MBGs具有大于500 m²/g的比表面积以及高密度的Si-OH基团。溶血率小于3%表明其具有优异的血液相容性。Cu-MBG纳米颗粒及其离子溶解对大肠杆菌和金黄色葡萄球菌具有抗菌作用,对癌细胞系具有显著的抗癌特性。此外,酸提取的Cu-MBG样品与人骨肉瘤细胞表现出显著的生物相容性,即使在浓度高达200μg/mL时也能保持相容性。这些发现表明,集成多种功能的Cu-MBG在生物活性、可降解性、血液和骨细胞相容性、癌症治疗以及抗菌功效方面具有潜力,为治疗传染病和骨相关缺损提供了可能性。